Search Within

Kitsada Wudhikarn

Formats
  1. Journal Article (8)
  2. Meeting Abstract (4)
  3. Review (2)
  4. Book Section (1)
Groups
  1. Center for Hematologic Malignancies (15)
  2. Department of Medicine (15)
  3. Hematologic Malignancies, Division of (15)
  4. Bone Marrow Transplant (11)
  5. Biostatistics Service (8)
  6. Epidemiology and Biostatistics (8)

More Groups

People
  1. Miguel-Angel Perales (11)
  2. Connie Batlevi (7)
  3. Craig Sauter (7)
  4. Gunjan Shah (7)
  5. Jessica Flynn (7)
  6. Maria Palomba (7)

More People

Years
  1. 2023 (2)
  2. 2022 (2)
  3. 2021 (2)
  4. 2020 (9)
Publications
  1. Blood Advances (4)
  2. Biology of Blood and Marrow Transplantation (2)
  3. Blood (2)
  4. Best Practice and Research: Clinical Haematology (1)
  5. Blood Cancer Journal (1)
  6. Bone Marrow Transplantation (1)

More Publications

Publishers
  1. American Society of Hematology (7)
  2. Elsevier Inc. (5)
  3. Nature Publishing Group (2)
  4. Taylor & Francis Group (1)

Results (15)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Real-world outcomes of brexucabtagene autoleucel ( brexu-cel) for relapsed or refractory (R/R) adult B-cell acute lymphoblastic leukemia (B-cell ALL): Evidence from the CIBMTR registry
    Meeting Abstract

    Bezerra, E.; Itani, T.; Wudhikarn, K.; Perales, M. A.; Yang, Y.; Gergis, U.; Aribi, A.; Hill, L. C.; Jain, N.; Leonard, J. T.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Low toxicity and excellent outcomes in patients with DLBCL without residual lymphoma at the time of CD19 CAR T-cell therapy
    Journal Article

    Wudhikarn, K.; Tomas, A. A.; Flynn, J. R.; Devlin, S. M.; Brower, J.; Bachanova, V.; Nastoupil, L. J.; McGuirk, J. P.; Maziarz, R. T.; Oluwole, O. O.; more...
    Blood Advances (2023)

    Fulltext@MSK | Save
  • Chimeric antigen receptor T cells and management of toxicities: Implications of biomarkers
    Book Section

    Wudhikarn, K.; Alarcón Tomas, A.; Murata, K.; Perales, M. A.
    In Ramanathan, L. V.; Fleisher, M.; Duffy, M. J. (Eds.) Cancer Biomarkers: Clinical Aspects and Laboratory Determination (2022)

    Fulltext@MSK | Save
  • Outcomes of relapsed B-cell acute lymphoblastic leukemia after sequential treatment with blinatumomab and inotuzumab
    Journal Article

    Wudhikarn, K.; King, A. C.; Geyer, M. B.; Roshal, M.; Bernal, Y.; Gyurkocza, B.; Perales, M. A.; Park, J. H.
    Blood Advances (2022)

    Fulltext@MSK | Save
  • Interventions and outcomes of adult patients with B-ALL progressing after CD19 chimeric antigen receptor T-cell therapy
    Journal Article

    Wudhikarn, K.; Flynn, J. R.; Rivière, I.; Gönen, M.; Wang, X.; Senechal, B.; Curran, K. J.; Roshal, M.; Maslak, P. G.; Geyer, M. B.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • The International Prognostic Index is associated with outcomes in diffuse large B cell lymphoma after chimeric antigen receptor T cell therapy
    Journal Article

    Garcia-Recio, M.; Wudhikarn, K.; Pennisi, M.; Alonso-Trillo, R.; Flynn, J.; Shouval, R.; Afuye, A. O.; Silverberg, M. L.; Batlevi, C. W.; Dahi, P.; more...
    Transplantation and Cellular Therapy (2021)

    Fulltext@MSK | Save
  • International prognostic index predicts outcomes in patients with relapsed and refractory large diffuse B cell lymphoma treated with commercial CAR T cells
    Meeting Abstract

    Garcia-Recio, M.; Wudhikarn, K.; Pennisi, M.; Alonso-Trillo, R.; Flynn, J.; Roni, S.; Batlevi, Y.; Silverberg, M. L.; Batlevi, C. W.; Brentjens, R.; more...
    Bone Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Future of CAR T cells in multiple myeloma
    Journal Article

    Wudhikarn, K.; Mailankody, S.; Smith, E. L.
    Hematology-American Society of Hematology Education Program (2020)

    Fulltext@MSK | Save
  • Dissecting factors influencing response to CAR T cell therapy in B lymphoid hematologic malignancies: From basic to practice
    Review

    Wudhikarn, K.; Park, J. H.
    Leukemia and Lymphoma (2020)

    Fulltext@MSK | Save
  • Infection during the first year in patients treated with CD19 CAR T cells for diffuse large B cell lymphoma
    Journal Article

    Wudhikarn, K.; Palomba, M. L.; Pennisi, M.; Garcia-Recio, M.; Flynn, J. R.; Devlin, S. M.; Afuye, A.; Silverberg, M. L.; Maloy, M. A.; Shah, G. L.; more...
    Blood Cancer Journal (2020)

    Fulltext@MSK | Save